Buchu

What Is Buchu?

Buchu is best known for its effects on the urinary tract. It’s a diuretic, increasing the flow of urine, and speeding filtration in the blood. It works differently to most diuretics, however, by increasing blood flow to the kidneys, allowing them to work harder on their own accord. Other diuretics tend to work by decreasing the reabsorption rates in the nephrons.

Buchu is a diuretic, but it’s also a urinary antiseptic. It’s effective for treating urinary tract infections in men and women. It has a much gentler action than other urinary antiseptics, which makes it useful for children, the elderly, and those with weak or chronically damaged urinary tracts.

What Is Buchu Used For?

Buchu’s main use is as a urinary antiseptic, and to increase urine flow. It’s useful for conditions like prostatitis, cystitis, and urethritis.

Buchu is also used as a mild laxative and carminative.

Fortunately, Buchu has a great flavour, similar to cranberry, making it a good choice for children or those who find it difficult to palate herbs.

Indications

• Genitourinary infections
• Cystitis
• Urethritis
• Prostatitis

Contraindications

• Pregnancy — avoid the essential oil and concentrated extracts (pulegone is an abortifacient)
• High-dose or prolonged essential-oil use (pulegone hepatotoxicity)

Traditional Uses

Western Herbal Medicine

The eclectics suggested buchu as an aromatic stimulant and tonic and used it to treat poor appetite, flatulence, and nausea. It was also commonly used in Europe to treat urinary tract infection and inflammation. ^{1Reference 1Lis-Balchin M et al. · 2001In vitroBuchu (Agathosma betulina and A. crenulata, Rutaceae) essential oils: their pharmacological action on guinea-pig ileum and antimicrobial activity on microorganisms — in vitro studyView study →}.

In modern times, buchu essential oil is often added to artificial fruit flavoring and is common in the food industry for this reason ^{1Reference 1Lis-Balchin M et al. · 2001In vitroBuchu (Agathosma betulina and A. crenulata, Rutaceae) essential oils: their pharmacological action on guinea-pig ileum and antimicrobial activity on microorganisms — in vitro studyView study →}. It’s often used in perfumes ^{8Reference 8Zárybnický T et al. · 2018ReviewHepatotoxicity of monoterpenes and sesquiterpenes — reviewView study →}.

The British Pharmacopoeia lists buchu as useful for a urinary antiseptic, and diuretic useful for cystitis, urethritis, and prostatitis. ^{4Reference 4Adedirin O et al. · 2025Density functional theory and molecular dynamics simulation-based bioprospection of Agathosma betulina essential oil metabolites against protein tyrosine phosphatase 1B — in silico studyView study →}.

South Africa

The Hottentots of South Africa used the leaves of buchu as a perfume. Most of its traditional medicinal usage in this region was for its ability to treat urinary tract disorders as well as for its carminative and laxative actions. ^{1,9Reference 1Lis-Balchin M et al. · 2001In vitroBuchu (Agathosma betulina and A. crenulata, Rutaceae) essential oils: their pharmacological action on guinea-pig ileum and antimicrobial activity on microorganisms — in vitro studyView study →Reference 9Gordon P · 2015ReviewA decades-long investigation of acute metabolism-based hepatotoxicity by herbal constituents: a case study of pennyroyal oil — reviewView study →}.

Botanical Information

Buchu is a small shrub from South Africa ^{4Reference 4Adedirin O et al. · 2025Density functional theory and molecular dynamics simulation-based bioprospection of Agathosma betulina essential oil metabolites against protein tyrosine phosphatase 1B — in silico studyView study →}.

Buchu is a member of the Rutaceae family of plants. This is also known as the citrus family, which includes as much as 2000 species distributed into 160 genera. The Agathosma genus contains about 140 different species.

The leaves of buchu are highly aromatic, and resemble a combination of black-currant and peppermint. ^{1Reference 1Lis-Balchin M et al. · 2001In vitroBuchu (Agathosma betulina and A. crenulata, Rutaceae) essential oils: their pharmacological action on guinea-pig ileum and antimicrobial activity on microorganisms — in vitro studyView study →}.

Agathosma is a member of the citrus (Rutaceae) family. It’s a shrub that can grow up to 2m in height, with rhomboid-obovate leaves.

The flowers have 5 whitish petals that develop into brown fruits containing 5 carpels.

Interestingly, recent evidence has surfaced to suggest that buchu has a particular synergistic relationship with a common soil yeast, which allows it to grow in the low nutrient soil it’s found in ^{7Reference 7Zonyane S et al. · 2013In vitroAntimicrobial interactions of Khoi-San poly-herbal remedies with emphasis on the combination Agathosma crenulata, Dodonaea viscosa and Eucalyptus globulus — in vitro studyView study →}. It has been suggested that this relationship plays a strong role in the medicinal constituent concentrations in the harvested plants. More research is needed.

Harvesting, Collection & Preparation

Buchu leaves are suggested to be of the highest quality medicinally while the plants are flowering or fruiting.

The Khoi-San of South Africa call any aromatic dusting herb buchu, which has led to some confusion in the region. There are currently many different species of herb referred to as buchu from the reason. The main species considered buchu for medicinal purposes however is Agathosma betulina. ^{1Reference 1Lis-Balchin M et al. · 2001In vitroBuchu (Agathosma betulina and A. crenulata, Rutaceae) essential oils: their pharmacological action on guinea-pig ileum and antimicrobial activity on microorganisms — in vitro studyView study →}.

Phytochemistry

Buchu’s activity centres on its essential oil (roughly 1.5–3.5% of the leaf), whose signature component is diosphenol — the “buchu camphor” thought to carry much of the urinary-antiseptic action and unique to this genus. The oil also carries large fractions of menthone (and its isomer isomenthone), limonene and the (toxic at high dose) ketone pulegone. Alongside the oil the leaf supplies a set of flavonoids — notably diosmin, rutin, hesperidin, diosmetin and quercetin — plus B vitamins, tannins, resin and mucilage. ^{1,2,3Reference 1Lis-Balchin M et al. · 2001In vitroBuchu (Agathosma betulina and A. crenulata, Rutaceae) essential oils: their pharmacological action on guinea-pig ileum and antimicrobial activity on microorganisms — in vitro studyView study →Reference 2Moolla A · 2008ReviewMoolla A, Viljoen AM. (2008). ‘Buchu’ — Agathosma betulina and Agathosma crenulata (Rutaceae): a review. J Ethnopharmacol. https://pubmed.ncbi.nlm.nih.gov/18725278/View study →Reference 3Brendler T · 2022ReviewBuchu (Agathosma betulina and A. crenulata): Rightfully Forgotten or Underutilized? — reviewView study →}.

Constituent Summary

Essential-oil components are given as a share of the volatile oil (which is ~1.5–3.5% of the leaf); flavonoids are present in much smaller, largely unquantified amounts. Oil composition varies widely between chemotypes and growing conditions.

Pharmacology & Research

The research base for buchu (Agathosma betulina) is small and, despite three centuries of commercial and medicinal use, remains almost entirely preclinical and traditional. No randomised controlled trial or human clinical study of buchu for any indication was identified; the evidence consists of a handful of in vitro pharmacology experiments, recent in silico modelling, ethnobotanical surveys, and two modern reviews that reach the same conclusion — the plant is commercially important but scientifically under-investigated ^{2,3Reference 2Moolla A · 2008ReviewMoolla A, Viljoen AM. (2008). ‘Buchu’ — Agathosma betulina and Agathosma crenulata (Rutaceae): a review. J Ethnopharmacol. https://pubmed.ncbi.nlm.nih.gov/18725278/View study →Reference 3Brendler T · 2022ReviewBuchu (Agathosma betulina and A. crenulata): Rightfully Forgotten or Underutilized? — reviewView study →}. The most concrete experimental finding is a smooth-muscle relaxant (spasmolytic) action of the essential oil on guinea-pig ileum, with a defined cyclic-AMP/calcium-channel mechanism ^{1Reference 1Lis-Balchin M et al. · 2001In vitroBuchu (Agathosma betulina and A. crenulata, Rutaceae) essential oils: their pharmacological action on guinea-pig ileum and antimicrobial activity on microorganisms — in vitro studyView study →}; the most interesting emerging signal is enzyme-level antidiabetic activity (PTP1B/DPP4 inhibition) reported in 2025–2026 in silico and essential-oil bioassay work ^{4,5Reference 4Adedirin O et al. · 2025Density functional theory and molecular dynamics simulation-based bioprospection of Agathosma betulina essential oil metabolites against protein tyrosine phosphatase 1B — in silico studyView study →Reference 5Adedirin O · 2026In vitroDual PTP1B/DPP4 inhibitory potential of Agathosma betulina, Cymbopogon citratus and Artemisia afra: structure-based modeling of phytochemical leads and essential oil bioassays — in vitro/in silico studyView study →}. A central caveat runs through everything: activity centres on the volatile oil, whose composition — including the potentially hepatotoxic ketone pulegone — varies widely between chemotypes and growing regions, so results do not transfer cleanly between an essential oil, a tincture, and a leaf tea.

0. Evidence by indication

Support is an experimental score I’m building — a composite weighted by study type (human > animal > in vitro > review) and study volume. It’s a beta: a fast way to rank strength of evidence at a glance, not a validated metric, and I’ll keep honing the formula over time. Each indication name links down to its write-up.

Indication	Support	Rests on
Antispasmodic	████░░░░░░ 38%	Single in vitro guinea-pig ileum study of the essential oil; defined cAMP/Ca²⁺-channel mechanism 1Reference 1Lis-Balchin M et al. · 2001In vitroBuchu (Agathosma betulina and A. crenulata, Rutaceae) essential oils: their pharmacological action on guinea-pig ileum and antimicrobial activity on microorganisms — in vitro studyView study →. No human data.
Diuretic (aqueretic)	███░░░░░░░ 30%	Pharmacopoeial and traditional use; the “aqueretic” (renal blood-flow) concept is a hypothesis, never tested experimentally in buchu 2,3Reference 2Moolla A · 2008ReviewMoolla A, Viljoen AM. (2008). ‘Buchu’ — Agathosma betulina and Agathosma crenulata (Rutaceae): a review. J Ethnopharmacol. https://pubmed.ncbi.nlm.nih.gov/18725278/View study →Reference 3Brendler T · 2022ReviewBuchu (Agathosma betulina and A. crenulata): Rightfully Forgotten or Underutilized? — reviewView study →.
Antidiabetic	███░░░░░░░ 27%	Two 2025–2026 A. betulina studies: in silico PTP1B/DPP4 docking plus an essential-oil enzyme bioassay 4,5Reference 4Adedirin O et al. · 2025Density functional theory and molecular dynamics simulation-based bioprospection of Agathosma betulina essential oil metabolites against protein tyrosine phosphatase 1B — in silico studyView study →Reference 5Adedirin O · 2026In vitroDual PTP1B/DPP4 inhibitory potential of Agathosma betulina, Cymbopogon citratus and Artemisia afra: structure-based modeling of phytochemical leads and essential oil bioassays — in vitro/in silico studyView study →. No cell, animal, or human data.
Anti-inflammatory	██░░░░░░░░ 24%	Constituent-level inference from the leaf’s venoactive flavonoids (diosmin, hesperidin, rutin) 2Reference 2Moolla A · 2008ReviewMoolla A, Viljoen AM. (2008). ‘Buchu’ — Agathosma betulina and Agathosma crenulata (Rutaceae): a review. J Ethnopharmacol. https://pubmed.ncbi.nlm.nih.gov/18725278/View study →; no whole-herb study.
Antimicrobial (urinary antiseptic)	██░░░░░░░░ 22%	The one direct test found little/no activity for A. betulina oil 1Reference 1Lis-Balchin M et al. · 2001In vitroBuchu (Agathosma betulina and A. crenulata, Rutaceae) essential oils: their pharmacological action on guinea-pig ileum and antimicrobial activity on microorganisms — in vitro studyView study →; combination activity was for A. crenulata, not this species 7Reference 7Zonyane S et al. · 2013In vitroAntimicrobial interactions of Khoi-San poly-herbal remedies with emphasis on the combination Agathosma crenulata, Dodonaea viscosa and Eucalyptus globulus — in vitro studyView study →.
Analgesic	██░░░░░░░░ 18%	Single study, and only as a silver-nanoparticle synthesis vehicle — not buchu as consumed 6Reference 6Chiguvare H et al. · 2016In vitroSynthesis of silver nanoparticles using buchu plant extracts and their analgesic properties — in vitro/in vivo studyView study →.

1. Antispasmodic

The single direct pharmacology study of buchu essential oil found a smooth-muscle relaxant (spasmolytic) action on guinea-pig ileum in vitro: at high concentration the oil was first spasmogenic, then spasmolytic, and the relaxant effect was post-synaptic, not atropine-like, and independent of adrenoceptors or guanylyl cyclase ^{1Reference 1Lis-Balchin M et al. · 2001In vitroBuchu (Agathosma betulina and A. crenulata, Rutaceae) essential oils: their pharmacological action on guinea-pig ileum and antimicrobial activity on microorganisms — in vitro studyView study →}. It was potentiated by the phosphodiesterase inhibitor rolipram and A. betulina oil additionally appeared to block calcium channels, together pointing to a cyclic-AMP-mediated mechanism ^{1Reference 1Lis-Balchin M et al. · 2001In vitroBuchu (Agathosma betulina and A. crenulata, Rutaceae) essential oils: their pharmacological action on guinea-pig ileum and antimicrobial activity on microorganisms — in vitro studyView study →}. This is a plausible basis for the traditional carminative and antispasmodic use, and it was tested on the essential oil — the relevant active fraction. Note that the tissue was gut smooth muscle, not the urinary tract.

Gap: one in vitro study, on ileum rather than bladder or ureter, with no dose-response in a living animal and no human confirmation.

2. Diuretic (aqueretic)

Increasing urine flow is buchu’s defining traditional use and the basis for its pharmacopoeial listing, yet no controlled experimental study — animal or human — was identified that measures a diuretic effect ^{2,3Reference 2Moolla A · 2008ReviewMoolla A, Viljoen AM. (2008). ‘Buchu’ — Agathosma betulina and Agathosma crenulata (Rutaceae): a review. J Ethnopharmacol. https://pubmed.ncbi.nlm.nih.gov/18725278/View study →Reference 3Brendler T · 2022ReviewBuchu (Agathosma betulina and A. crenulata): Rightfully Forgotten or Underutilized? — reviewView study →}. The mechanistic story usually offered is the “aqueretic” concept: that buchu (like juniper, goldenrod and parsley) increases renal blood flow and glomerular filtration rather than acting on tubular ion handling as pharmaceutical diuretics do. This is a reasonable hypothesis but, for buchu specifically, it remains untested — it rests on traditional and secondary-source assertion, not measurement.

Gap: the herb’s headline action has never been experimentally verified; there is no measured urine-output or GFR data for buchu in any species.

3. Antidiabetic

The most recent and specific new signal is enzyme-level antidiabetic activity. A 2025 density-functional-theory and molecular-dynamics study modelled A. betulina essential-oil metabolites against protein tyrosine phosphatase 1B (PTP1B), a validated type-2-diabetes target, predicting favourable binding ^{4Reference 4Adedirin O et al. · 2025Density functional theory and molecular dynamics simulation-based bioprospection of Agathosma betulina essential oil metabolites against protein tyrosine phosphatase 1B — in silico studyView study →}. A 2026 follow-up extended this to dual PTP1B/DPP4 inhibition, combining structure-based modelling of phytochemical leads with essential-oil bioassays ^{5Reference 5Adedirin O · 2026In vitroDual PTP1B/DPP4 inhibitory potential of Agathosma betulina, Cymbopogon citratus and Artemisia afra: structure-based modeling of phytochemical leads and essential oil bioassays — in vitro/in silico studyView study →}. Both are early-stage and computation-dominant, but they are among the few studies to interrogate a defined therapeutic mechanism in this exact species.

Gap: entirely in silico plus a single enzyme bioassay — no cell-culture, animal, or human glucose data, and the modelled metabolites may not reach relevant concentrations from any normal preparation.

4. Anti-inflammatory

Buchu leaf supplies a set of venoactive flavonoids — diosmin, hesperidin, rutin, diosmetin and quercetin — that are individually well characterised as anti-inflammatory and vasoprotective agents ^{2Reference 2Moolla A · 2008ReviewMoolla A, Viljoen AM. (2008). ‘Buchu’ — Agathosma betulina and Agathosma crenulata (Rutaceae): a review. J Ethnopharmacol. https://pubmed.ncbi.nlm.nih.gov/18725278/View study →}. On that basis an anti-inflammatory action is mechanistically plausible. However, this is constituent-level inference: no study has demonstrated an anti-inflammatory effect of buchu extract or oil itself, and the flavonoids are present in small, largely unquantified amounts relative to the dominant volatile oil.

Gap: the inference runs from isolated-compound literature, not from any test of buchu; flavonoid content is low and unquantified, so whole-herb activity cannot be assumed.

5. Antimicrobial (urinary antiseptic)

This is buchu’s most famous claim and its weakest experimental footing. In the one direct test, neither A. betulina nor A. crenulata essential oil showed antimicrobial action against Enterococcus hirae or Pseudomonas aeruginosa, and only very low activity against Escherichia coli, Saccharomyces cerevisiae and Staphylococcus aureus — the authors concluded there was “little potential for these oils as antimicrobial agents” ^{1Reference 1Lis-Balchin M et al. · 2001In vitroBuchu (Agathosma betulina and A. crenulata, Rutaceae) essential oils: their pharmacological action on guinea-pig ileum and antimicrobial activity on microorganisms — in vitro studyView study →}. A separate 2013 study did find useful antibacterial activity, but for a three-herb Khoi-San combination built on A. crenulata (a different species), not A. betulina alone ^{7Reference 7Zonyane S et al. · 2013In vitroAntimicrobial interactions of Khoi-San poly-herbal remedies with emphasis on the combination Agathosma crenulata, Dodonaea viscosa and Eucalyptus globulus — in vitro studyView study →}. The traditional “urinary antiseptic” reputation is therefore not supported by direct testing of this species.

Gap: the primary evidence is essentially negative for A. betulina; positive combination data belong to a different species and cannot be transferred, and no study has tested urinary-tract antisepsis at concentrations achievable in urine.

6. Analgesic

A 2016 study reported analgesic activity, but the design limits its relevance to buchu as consumed: buchu ethanolic extract was used to synthesise silver nanoparticles, and the analgesic effect was strongest for the nanoparticle–extract combination, exceeding both aspirin and the extract alone ^{6Reference 6Chiguvare H et al. · 2016In vitroSynthesis of silver nanoparticles using buchu plant extracts and their analgesic properties — in vitro/in vivo studyView study →}. The finding is about an engineered silver-nanoparticle material, not a tincture, tea, or oil, so it cannot be read as an analgesic property of the herb itself.

Gap: severe preparation mismatch — the tested agent is a silver-nanoparticle composite, not any form of buchu in traditional or commercial use; a single study with no replication.

Mechanisms

Mechanism	Drives	Key compounds
Volatile oil; smooth-muscle relaxation via ↑cAMP and Ca²⁺-channel block; pulegone bioactivated by CYP450 to hepatotoxic menthofuran	antispasmodic; also the safety liability	diosphenol, menthone, pulegone
Renal/urinary excretion of aromatic terpenes (basis of the “aqueretic” hypothesis)	diuretic (proposed, untested)	limonene
NF-κB / eicosanoid modulation, vascular tone (constituent-level)	anti-inflammatory (inferred)	diosmin, hesperidin, rutin, diosmetin
PTP1B / DPP4 binding (in silico)	antidiabetic (emerging)	quercetin, diosmetin

Clinical trials

No registered clinical trials were identified for buchu (Agathosma betulina) for any indication — a ClinicalTrials.gov search on “buchu” and “Agathosma” returned zero studies. The evidence base is entirely preclinical, in silico, and traditional.

Completed	Planned	Terminated	Preclinical
0	0	0	~6 on A. betulina

Last checked: July 2026.

Dosage

Buchu is taken traditionally as a leaf tea, tincture or liquid extract; a common Western-herbal figure is a 1:2 liquid extract at 15–30 mL per week. No primary study has established or validated a therapeutic dose — the evidence base is preclinical and traditional — so the figures below are pharmacopoeial and traditional rather than research-derived. Essential-oil intake should be kept distinct from tincture or tea: pulegone exposure from the concentrated oil can be an order of magnitude higher than from a dilute leaf preparation.

The research literature yields no measured, indication-specific doses for buchu; the table below records the traditional preparations only, and no dried-herb equivalent can be estimated from experimental data.

Indication	Preparation	Dose	Est. dried-herb equivalent	Source
Urinary tract (traditional)	1:2 liquid extract	15–30 mL / week	No Data — not research-derived	2Reference 2Moolla A · 2008ReviewMoolla A, Viljoen AM. (2008). ‘Buchu’ — Agathosma betulina and Agathosma crenulata (Rutaceae): a review. J Ethnopharmacol. https://pubmed.ncbi.nlm.nih.gov/18725278/View study →

Traditional Dosage

Traditional Western and South African herbalism used buchu leaf as an infusion or tincture for urinary complaints, and as a carminative for digestive upset.

System	Preparation	Dose
Western herbal	1:2 liquid extract	15–30 mL / week
Western herbal	Leaf infusion (tea)	1–2 g dried leaf per cup

Safety

Buchu’s essential oil contains pulegone, the same monoterpene ketone responsible for the toxicity of pennyroyal oil; pulegone is bioactivated by liver CYP450 enzymes to reactive metabolites (chiefly menthofuran) that deplete glutathione and can cause dose-dependent hepatotoxicity ^{8,9,10Reference 8Zárybnický T et al. · 2018ReviewHepatotoxicity of monoterpenes and sesquiterpenes — reviewView study →Reference 9Gordon P · 2015ReviewA decades-long investigation of acute metabolism-based hepatotoxicity by herbal constituents: a case study of pennyroyal oil — reviewView study →Reference 10Zárybnický T et al. · 2018In vitroInter-individual variability in acute toxicity of R-pulegone and R-menthofuran in human liver slices — in vitro studyView study →}. Reported pulegone levels in buchu oil range from under 5% to as high as 34%, and oil composition varies widely by chemotype and growing region, so the risk of a given product is not predictable from the label ^{11,13Reference 11Cohen SM et al. · 2020ReviewFEMA GRAS assessment of natural flavor complexes: mint, buchu, dill and caraway derived flavoring ingredients — reviewView study →Reference 13Mnisi NH et al. · 2026Geographic influence on secondary metabolite profiles in leaves of the endemic Agathosma betulina in the Western Cape — analytical studyView study →}. Pulegone is a recognised abortifacient, so buchu essential oil and concentrated extracts should be avoided in pregnancy; casual culinary flavour use and dilute leaf teas carry far lower exposure, and buchu leaf oil holds FEMA GRAS status only at flavouring levels of intake ^{11Reference 11Cohen SM et al. · 2020ReviewFEMA GRAS assessment of natural flavor complexes: mint, buchu, dill and caraway derived flavoring ingredients — reviewView study →}. EFSA has separately assessed the oil as a feed additive ^{12Reference 12Bampidis V et al. · 2022ReviewSafety and efficacy of a feed additive consisting of an essential oil from the leaves of Agathosma betulina/A. crenulata — reviewView study →}.

No human or in vivo drug-interaction study of buchu was identified. Pulegone’s CYP450 bioactivation raises a theoretical interaction concern with CYP-metabolised drugs and CYP inducers, but this has not been tested for buchu specifically — treat it as not assessed rather than cleared. The absence of reported buchu poisoning cases should not be read as evidence of safety; pulegone toxicity is well documented for the same molecule in pennyroyal.

Pregnancy & lactation

Avoid the essential oil and concentrated extracts. Pulegone is a recognised abortifacient, and buchu oil can carry it at up to ~34% ^{11,13Reference 11Cohen SM et al. · 2020ReviewFEMA GRAS assessment of natural flavor complexes: mint, buchu, dill and caraway derived flavoring ingredients — reviewView study →Reference 13Mnisi NH et al. · 2026Geographic influence on secondary metabolite profiles in leaves of the endemic Agathosma betulina in the Western Cape — analytical studyView study →}; no buchu-specific reproductive-toxicity study exists, so the caution derives from the known activity of the molecule rather than from direct testing. Dilute leaf tea and culinary flavour use represent far lower exposure, but medicinal or concentrated use in pregnancy should be avoided. Lactation has not been assessed.

References

1. Lis-Balchin M, Hart S, Simpson E. (2001). Buchu (Agathosma betulina and A. crenulata, Rutaceae) essential oils: their pharmacological action on guinea-pig ileum and antimicrobial activity on microorganisms — in vitro study. J Pharm Pharmacol. https://pubmed.ncbi.nlm.nih.gov/11341377/
2. Moolla A, Viljoen AM. (2008). ‘Buchu’ — Agathosma betulina and Agathosma crenulata (Rutaceae): a review. J Ethnopharmacol. https://pubmed.ncbi.nlm.nih.gov/18725278/
3. Brendler T, Abdel-Tawab M. (2022). Buchu (Agathosma betulina and A. crenulata): Rightfully Forgotten or Underutilized? — review. Front Pharmacol. https://pubmed.ncbi.nlm.nih.gov/35197854/
4. Adedirin O, Abdulsalam RA, Nasir-Naeem KO, et al. (2025). Density functional theory and molecular dynamics simulation-based bioprospection of Agathosma betulina essential oil metabolites against protein tyrosine phosphatase 1B — in silico study. Heliyon. https://pubmed.ncbi.nlm.nih.gov/39991230/
5. Adedirin O, Sabiu S. (2026). Dual PTP1B/DPP4 inhibitory potential of Agathosma betulina, Cymbopogon citratus and Artemisia afra: structure-based modeling of phytochemical leads and essential oil bioassays — in vitro/in silico study. Comput Struct Biotechnol J. https://pubmed.ncbi.nlm.nih.gov/42007177/
6. Chiguvare H, Oyedeji OO, Matewu R, et al. (2016). Synthesis of silver nanoparticles using buchu plant extracts and their analgesic properties — in vitro/in vivo study. Molecules. https://pubmed.ncbi.nlm.nih.gov/27314316/
7. Zonyane S, Van Vuuren SF, Makunga NP. (2013). Antimicrobial interactions of Khoi-San poly-herbal remedies with emphasis on the combination Agathosma crenulata, Dodonaea viscosa and Eucalyptus globulus — in vitro study. J Ethnopharmacol. https://pubmed.ncbi.nlm.nih.gov/23588096/
8. Zárybnický T, Boušová I, Ambrož M, et al. (2018). Hepatotoxicity of monoterpenes and sesquiterpenes — review. Arch Toxicol. https://pubmed.ncbi.nlm.nih.gov/28905185/
9. Gordon P, Khojasteh SC. (2015). A decades-long investigation of acute metabolism-based hepatotoxicity by herbal constituents: a case study of pennyroyal oil — review. Drug Metab Rev. https://pubmed.ncbi.nlm.nih.gov/25512112/
10. Zárybnický T, Matoušková P, Lancošová B, et al. (2018). Inter-individual variability in acute toxicity of R-pulegone and R-menthofuran in human liver slices — in vitro study. Int J Mol Sci. https://pubmed.ncbi.nlm.nih.gov/29921785/
11. Cohen SM, Eisenbrand G, Fukushima S, et al. (2020). FEMA GRAS assessment of natural flavor complexes: mint, buchu, dill and caraway derived flavoring ingredients — review. Food Chem Toxicol. https://pubmed.ncbi.nlm.nih.gov/31604112/
12. Bampidis V, Azimonti G, Bastos ML, et al. (EFSA FEEDAP Panel). (2022). Safety and efficacy of a feed additive consisting of an essential oil from the leaves of Agathosma betulina/A. crenulata — review. EFSA J. https://pubmed.ncbi.nlm.nih.gov/35281638/
13. Mnisi NH, Gunununu RP, Dukashe L, et al. (2026). Geographic influence on secondary metabolite profiles in leaves of the endemic Agathosma betulina in the Western Cape — analytical study. Int J Mol Sci. https://pubmed.ncbi.nlm.nih.gov/42196464/